EGL chart, page-59

First 59 Last

Share
Profile

Follow
capital3157

1,990 Posts.

303

25/03/21

17:59

Post #: 52044877
Share

Originally posted by bellcurve: ↑

Bricklebar, am sure these things are coming, in due course.

the combination of a new CEO and a revitalized board are already in place and we're seeing the impact of these moves already in share price, market cap, volumes traded etc.

there is no doubt a lot taking place beneath the surface too, which isn't newsworthy as such but makes the EGL vessel ever more seaworthy.

i can't remember if the company is required by ASX to report quarterly or half yearly.

but as it's coming up to the end of the March quarter, i'd like to see before too long issue of full year guidance for key metrics or confirmation of existing guidance. In part just to limit the risk from any negative surprises.

EGL reported in the half yearly at the end of February that it had around A$764k in the bank.

this strikes me as running too thin.

thinking out loud here and not being privy to any discussions within the company, if EGL wants to expand it will need capital to do so, and might tap shareholders to fund a decent plan.

if stellar SP gains continue, a CR at 10c to raise $5m might be possible in coming months.

yes this implies dilution of 20-25% or thereabouts but should be seen in a positive light.

the company would then be well capitalized to grow the business. and shareholders likely would benefit from increased liquidity, something that has always been a problem to date.

Expand

Actually, the more I think about your cap raise @10cps idea the more I like it.
Not only would it give balance sheet strength...

It would dilute the Richardson's further and lessen their control which from history can only be a good thing.

EGL Price at posting: 7.2¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 59 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 26.0¢		Change -0.005(1.89%)		Mkt cap ! $98.92M

Open	High	Low	Value	Volume
26.5¢	26.5¢	25.5¢	$2.181K	8.383K

Buyers (Bids)

No.	Vol.	Price($)
3	5836	25.5¢

Sellers (Offers)

Price($)	Vol.	No.
26.0¢	33080	1

View Market Depth

No.	Vol.	Price($)
3	5836	0.255
5	179136	0.250
4	145537	0.245
3	184160	0.240
1	2500	0.235

Price($)	Vol.	No.
0.260	33080	1
0.265	53635	2
0.270	67759	4
0.275	34978	2
0.280	71407	5

Last trade - 12.37pm 27/06/2025 (20 minute delay)

EGL (ASX) Chart

EGL chart, page-59

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

EGL chart, page-59

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News